Assessment of pharmacodynamics of a new "controlled release" form of diazepam (Valium CR Roche) by quantitative EEG and psychometric analysis in neurotic subjects.
D000328:Adult; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D003975:Diazepam / Q000008:administration & dosage* / Q000494:pharmacology; D004311:Double-Blind Method; D004569:Electroencephalography; D006801:Humans; D008568:Memory / Q000187:drug effects; D009497:Neurotic Disorders / Q000188:drug therapy*; D011594:Psychometrics; D011595:Psychomotor Agitation / Q000188:drug therapy; D011897:Random Allocation; D013997:Time Factors
D003692:Delayed-Action Preparations; D003975:Diazepam